| Name | AZ1495 |
|---|
| Description | AZ1495 (compound 28) is an oral active inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), with IC50 values of 5 nM and 23 nM for IRAK4 and IRAK1, respectively. Shows activity in treatment of mutant MYD88L265P diffuse large B-cell lymphoma (DLBCL)[1]. |
|---|---|
| Related Catalog | |
| Target |
IRAK4:5 nM (IC50) IRAK1:23 nM (IC50) CLK1:50 nM (IC50) CLK2:5 nM (IC50) CLK4:8 nM (IC50) haspin:4 nM (IC50) |
| References |
| Molecular Formula | C21H31N5O2 |
|---|---|
| Molecular Weight | 385.50 |
| Storage condition | 2-8℃ |